Organization
Syndax Pharmaceuticals, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Syndax Pharmaceuticals, Inc.
... are now active. Venture capital-funded companies in epigenetics include Constellation Pharmaceuticals and Syndax Pharmaceuticals. North America dominated the overall revenue, due to the, increasing funds ...
... Genentech and Syndax have expanded their exploration of the effects of combining HDAC and PD-L1 ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... (NASDAQ:PRAA), Materion Corporation (NYSE:MTRN), Second Sight Medical Products, Inc. (NASDAQ:EYES), and Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified ...
... uniQure NV, Ra Pharmaceuticals, Inc., Reata Pharmaceuticals Inc., Strongbridge Biopharma plc, Syndax Pharmaceuticals Inc., Sienna Biopharmaceuticals, Inc., Savara Inc., Tocagen Inc., Tetraphase Pharmaceuticals Inc., TherapeuticsMD ...
... Pharmaceuticals Nasdaq RETA Reata Pharmaceuticals Nasdaq SBBP Strongbridge Biopharma plc Nasdaq SNDX Syndax Pharmaceuticals Nasdaq SNNA Sienna Biopharmaceuticals Nasdaq SVRA Savara Inc. Nasdaq TOCA Tocagen ...
... CEO and is a member of the board of directors of Syndax Pharmaceuticals, Inc. Dr. Morrison also currently serves as a managing director of MPM ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... WALTHAM, Mass. - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... WALTHAM, Mass. - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... WALTHAM - Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in ...
... Clinical Development for Pfizer. Briggs is currently Chief Executive Officer of Syndax Pharmaceuticals Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer ...
... Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in ...
... Mr. Shea currently serves as Chief Financial Officer and Treasurer of Syndax Pharmaceuticals, Inc., and previously served as a member of its board of directors ...
... WALTHAM, Mass - Syndax Pharmaceuticals, Inc. ('Syndax,' the 'Company' or 'we') (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical stage biopharmaceutical ...
... Syndax (Nasdaq: SNDX) announced today that it will release its second quarter 2017 financial ...
Want to see the full history on Syndax Pharmaceuticals, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial